The company said the Moderna Innovation and Technology Centre (MITC) at the Harwell Science and Innovation Campus, near Chilton, is the UK’s first facility to manufacture mRNA jabs onshore. The facility can make up to 100 million doses per year, rising to 250 million in a pandemic, and will create around 150 highly skilled jobs, the Government said. Last week, UK pharmaceutical giant GSK revealed plans to put nearly £22 billion into US research and development and manufacturing over the next five years. Days later, AstraZeneca announced it had paused plans to invest £200 million at a Cambridge research site. Health Secretary Wes Streeting said the “new cutting-edge facility” in Oxfordshire marks the “next pivotal moment in boosting our nation’s health, innovation and economy”.
